TPH1 and depressive symptom measurement: This result may indicate that CUMS leads to a decrease in TH, PAH, and TPH activity and that the concentrations of synthetic catecholamine neurotransmitters, tyrosine, and phenylalanine are reduced, resulting in the symptoms of depression.